Forum: Articles of Interest
08-14-2006, 06:15 PM
|
|
Replies: 0
Views: 1,690
3 Week Herceptin is Safe
[3042] Updated efficacy and safety analyses of 3-weekly Herceptin monotherapy in women with HER2-positive metastatic breast cancer: results from twelve months of follow-up to a phase II study.
...
|
